Circulation

Circulation is a scientific journal published by Lippincott Williams & Wilkins for the American Heart Association. The journal publishes articles related to research in and the practice of cardiovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research. From 1996 to 2004, its impact factor has remained close to 10. As of 2009, its impact factor is 14.595 and it ranks first among journals in the Cardiac and Cardiovascular Systems, Hematology, Peripheral Vascular Disease categories. 2008 saw the appearance of six subspecialty journals. The first edition of Circulation: Arrhythmia and Electrophysiology (Circ Arrhythm Electrophysiol) appeared in April 2008, followed by an edition dedicated to heart failure in May titled Circulation: Heart Failure (Circ Heart Fail). The remaining four journals launched once per month from July through October 2008. In order of release they were, Circulation: Cardiovascular Imaging (Circ Cardiovasc Imaging), Circulation: Cardiovascular Interventions (Circ Cardiovasc Intervent), Circulation: Cardiovascular Quality and Outcomes (Circ

Publisher
Lippincott Williams & Wilkins
Country
United States
History
1950–present
Impact factor
14.595 (2009)

Some content from Wikipedia, licensed under CC BY-SA

Cardiology

Deadly heart problem might not be so deadly

An incurable condition called hypertrophic cardiomyopathy may be less deadly than previously thought, according to a new study of sudden cardiac deaths among young people.

Cardiology

American Indians may have a higher risk for irregular heartbeat

Irregular heartbeat or atrial fibrillation (AFib) occurred more often among American Indians than among other racial and ethnic groups, according to new research published in Circulation, the American Heart Association's ...

Genetics

AI identifies genes linked to heart failure

Genetic research led by Queen Mary University of London could open the way to earlier identification of people at risk of heart failure and to the development of new treatments.

page 1 from 50